2Dormond O,Ruegg C.Regulation of endothelial cell integrin function and angiogenesis by COX-2,cAMP and Protein Kinase A.Thromb Haemost,2003,90:577～585.
2Brummel kamp TR, Ni jman SM, Dirac AM, et al. Loss of the cylin dromatosis tumor suppressor inhibits apoptosis by activating NF-kappa B[J]. Nature,2003,424:738-739.
3HuaZou.Ahuman. Protein homologous to C. Elegonsced-4, partici- Pates in cytoehrome -c-dePendent,activation of caspase-3 Cell [J]. Med Pediatr Oneol, 2006,90:405 -413.
4Ilmore TD. The Rel / nf-kappa B / I kappa B signal tmnsduction path- way and cancer[J]. Cancer Treat Res, 2006,115:241-265.
5Chaud hary, P.M, M.T. Eby, A. Jasmin, et al. Activation of the NF-kappaB pathway by caspase-3 and its homologs [J]. Oncogene, 2005,19:4451-4460.
6Gruker BM. Trcmscription factor NF-kB: a new perspective in anti- cancer therapy[J]. Postepy Biochem, 2004.50(2): 118-130.
7Suh Rabson A.B.NF-kB activation in human prostate cancer:important mediator or epiphenomenon? [J]. J cell Biochem, 2004, 91 (1): 100-117.
8Alexander Golks, Dirk Brenner, Peter H. Krammer, and Inna N. Lavrik, The selective inhibit ofNF-kB (PDTC)induces NF-κ B acti- vation[J].Cancer Res, 2006,15:245-248.
9Jonsson G, Panlie S, Grandien A, et al. High level of caspase-3 corre- lates with resistance to death receptor induced apoptosis in bladder carcinoma cells [J]. Anticancer Res, 2005,23 (2):1213-1218.
10Persad R, Liu C, Wu TT, et al. Over expression of caspase-3 in hepa- to cellular carcinomas[J]. Modem Pathology, 2004,17:861-867.
